Navigation Links
Sysmex Supports Illinois Chapter Leukemia and Lymphoma Society
Date:7/23/2009

MUNDELEIN, Ill., July 23 /PRNewswire/ -- Sysmex today announced its customer appreciation dinner fundraiser for the Illinois Chapter of The Leukemia & Lymphoma Society (LLS) has resulted in a combined company/customer donation of $20,000 for LLS. Monies will be directed toward a general fund which supports blood cancer research and patient services. The Sysmex customer appreciation dinner fundraiser was held during the American Association of Clinical Chemistry's (AACC) annual meeting in Chicago July 19 - 23. The fundraising event for LLS corresponds with the state location of Sysmex's headquarters for the Americas and with the location of the 2009 AACC meeting. The Leukemia & Lymphoma Society is the world's largest voluntary health agency dedicated to blood cancer.

"On behalf of Sysmex, our board of directors and our employees, we want to thank our customers for their generosity in joining us in our efforts to support the Leukemia & Lymphoma Society as they work to eradicate hematological cancers. I trust our joint donation will be especially meaningful to the organization in these challenging economic times. We are all honored to have been given the opportunity to help," said John Kershaw, CEO, Sysmex America, Inc.

"The Leukemia & Lymphoma Society is proud to partner with Sysmex, and honored to be the beneficiary of their generosity," stated Pam Swenk, Executive Director, Illinois Chapter of The Leukemia & Lymphoma Society. "It is somehow appropriate that the global leader in healthcare testing equipment and technology be paired with the leader in the fight against blood cancer to meet the mission of the LLS. Our heartfelt thanks go to Mr. Kershaw and Sysmex."

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society (R) (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.

Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org or contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET. www.lls.org.

About Sysmex America, Inc.

Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems. Serving customers for over 40 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide. For more information about Sysmex, please visit www.sysmex.com/usa.


'/>"/>
SOURCE Sysmex America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sysmex America Debuts High-end Sample Management System During AACC
2. Sysmex America Receives Highest Vendor Designation from MedAssets Supply Chain Systems
3. Sysmex America Names Industry Veteran to Business Development Post
4. Sysmex America Honored by Premier Healthcare Alliance for Exceptional Supplier Performance
5. DaVita Study Demonstrates Clinical Application of Sysmex Reticulocyte Hemoglobin Equivalent (RET-He) Parameter
6. BioReference Laboratories Partners With Sysmex America
7. Siemens and Sysmex Renew Global Agreement
8. Sysmex Corporation Announces Organizational Changes
9. Sysmex America Introduces On Demand Middleware Training Tool
10. Sysmex Customer Satisfaction Ranks Highest in Independent Market Research
11. Sysmex America to Release e-Verify(TM), Powered By SNCS(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... ... educational assistance management solution to the exhibit floor for the 2017 HIMSS ... , From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental ... for each and every seminar, session and class she offers. At the ... tools which help energize creativity, focus mental functions, enhance athletic focus and skill ...
(Date:2/17/2017)... ... February 17, 2017 , ... Qualis Health, one of ... the 8th Annual DecisionHealth Platinum Awards in recognition of its innovative healthcare management ... recognized across multiple award categories, highlighting four of the organization’s current programs:, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Program ... , Trinity Health and the U.S. Soccer Foundation announced today that they have ... communities. Soccer for Success, the Foundation’s soccer mentoring program, teaches kids the fundamentals ...
(Date:2/17/2017)... ... 2017 , ... Pharmica Consulting attended CHI's 8th Annual SCOPE ... trial planning and management. Pharmica discussed the importance of effective project management, data ... by Pharmica’s booth were able to demo its cloud-based Resource Management Tool, ...
Breaking Medicine News(10 mins):
(Date:2/19/2017)... 19, 2017  nThrive™, an independent Patient-to-Payment? solutions ... thought leadership at the 2017 HIMSS Conference. The ... award from KLAS. nThrive will host ... how market trends shape the holistic, integrated revenue ... comprehensive Patient Access solution. The panel will reveal ...
(Date:2/18/2017)... HILL, N.C. , Feb. 17, 2017  Pharmaceutical companies ... insights about products either in development or already on the ... have forced the pharma industry to alter how it manages ... boards, consulting leader Best Practices, LLC conducted a new study ... ...
(Date:2/17/2017)... Feb. 17, 2017 Theravance Biopharma, Inc. ... the "Company") today announced the presentation of positive ... orally administered pan-Janus kinase (JAK) inhibitor designed to ... Congress of the European Crohn,s and Colitis Organization ... further data from its completed Phase 1 study ...
Breaking Medicine Technology: